GLP1 Guide

GLP1 Guide

👁️ A new study on GLP1's eye-related risk

GLP1 eye risks are in focus, with a surprising result.

Sep 20, 2025
∙ Paid

One of the biggest emerging risks of using GLP1s has been the link between GLP1s and vision loss — whether via NAION or macular degeneration.

We’ve covered this before:

The link between Semaglutide & vision loss (NAION)

The link between Semaglutide & vision loss (NAION)

GLP1 Guide
·
October 25, 2024
Read full story
🚨 A new risk? Macular Degeneration

🚨 A new risk? Macular Degeneration

GLP1 Guide
·
July 2, 2025
Read full story

Some new research (a study, not a trial) has emerged with regards to the eye related risks of GLP1s, and the results are surprising — they’re not as negative as one would imagine.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 GLP1 Guide · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture